Bio-Techne (TECH) Change in Receivables (2009 - 2026)

Bio-Techne's Change in Receivables history runs 18 years deep, the most recent figure standing at $31.3 million for Q1 2026.

• In Q1 2026, Change in Receivables rose 99.48% year-over-year to $31.3 million; the TTM figure through Mar 2026 stood at -$20.9 million (down 265.5% YoY), while the FY2025 annual figure was -$34.1 million, down 266.23% from the prior year.
• Change in Receivables for Q1 2026 stood at $31.3 million, up from -$941000.0 in the prior quarter.
• The five-year high for Change in Receivables was $51.6 million in Q1 2022, with the low at -$28.9 million in Q2 2025.
• The 5-year median for Change in Receivables is $92000.0 (2023), against an average of $3.7 million.
• The sharpest annual moves came in 2022 and 2024: Change in Receivables plunged 576.63% in 2022, then surged 19380.43% in 2024.
• Bio-Techne's Change in Receivables stood at $5.9 million in 2022, then tumbled by 180.1% to -$4.7 million in 2023, then soared by 113.16% to $623000.0 in 2024, then plunged by 251.04% to -$941000.0 in 2025, then surged by 3421.57% to $31.3 million in 2026.
• Business Quant data shows TECH's Change in Receivables at $31.3 million in Q1 2026, -$941000.0 in Q4 2025, and -$22.4 million in Q3 2025.